Ripretinib intrapatient dose escalation after disease progression provides clinically meaningful outcomes in advanced gastrointestinal stromal tumour

Autor: George, Suzanne, Chi, Ping, Heinrich, Michael C., von Mehren, Margaret, Jones, Robin L., Ganjoo, Kristen, Trent, Jonathan, Gelderblom, Hans, Razak, Albiruni A., Gordon, Michael S., Somaiah, Neeta, Jennings, Julia, Meade, Julie, Shi, Kelvin, Su, Ying, Ruiz-Soto, Rodrigo, Janku, Filip
Zdroj: In European Journal of Cancer September 2021 155:236-244
Databáze: ScienceDirect
Externí odkaz: